VYNE Therapeutics, Inc. (VYNE)
0.6101
-0.01
(-2.35%)
USD |
NASDAQ |
Apr 14, 16:00
0.6101
0.00 (0.00%)
After-Hours: 20:00
VYNE Therapeutics Total Liabilities (Quarterly) : 2.395M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Apellis Pharmaceuticals, Inc. | 705.11M |
| ACADIA Pharmaceuticals, Inc. | 336.80M |
| Alnylam Pharmaceuticals, Inc. | 4.236B |
| Savara, Inc. | 50.30M |
| BioMarin Pharmaceutical, Inc. | 1.507B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 30.16M |
| Shareholders Equity (Quarterly) | 27.76M |
| Current Ratio | 12.53 |
| Net Debt Paydown Yield | 0.13% |